![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SYTL3 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of SYTL3 mRNA | CTD | PMID:23649840 | SYTL3 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | SYTL3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sytl3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SYTL3 promoter] | CTD | PMID:19654925 | SYTL3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SYTL3 mRNA | CTD | PMID:32109520 | SYTL3 | Human | acetamide | increases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of SYTL3 mRNA | CTD | PMID:31881176 | SYTL3 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SYTL3 mRNA | CTD | PMID:22100608 | SYTL3 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of SYTL3 gene | CTD | PMID:27153756 | SYTL3 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SYTL3 mRNA | CTD | PMID:23724009 more ... | SYTL3 | Human | all-trans-retinoic acid | multiple interactions | ISO | Sytl3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYTL3 mRNA | CTD | PMID:36189433 | SYTL3 | Human | alpha-Zearalanol | multiple interactions | ISO | Sytl3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SYTL3 mRNA | CTD | PMID:35163327 | SYTL3 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of SYTL3 mRNA | CTD | PMID:24449571 | SYTL3 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SYTL3 mRNA | CTD | PMID:33212167 | SYTL3 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SYTL3 mRNA | CTD | PMID:20064835 | SYTL3 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SYTL3 5' UTR | CTD | PMID:27901495 | SYTL3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SYTL3 exon more ... | CTD | PMID:27901495 and PMID:30157460 | SYTL3 | Human | benzo[a]pyrene | decreases expression | ISO | Sytl3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SYTL3 mRNA | CTD | PMID:22228805 | SYTL3 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of SYTL3 intron | CTD | PMID:30157460 | SYTL3 | Human | Benzo[ghi]perylene | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in increased expression of SYTL3 mRNA | CTD | PMID:26377693 | SYTL3 | Human | bisphenol A | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SYTL3 mRNA | CTD | PMID:25181051 | SYTL3 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYTL3 gene | CTD | PMID:31601247 | SYTL3 | Human | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SYTL3 gene | CTD | PMID:31601247 | SYTL3 | Human | cadmium dichloride | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of SYTL3 mRNA | CTD | PMID:33453195 | SYTL3 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SYTL3 mRNA | CTD | PMID:26485663 | SYTL3 | Human | carbon nanotube | decreases expression | ISO | Sytl3 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of SYTL3 mRNA | CTD | PMID:25554681 | SYTL3 | Human | DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of SYTL3 mRNA | CTD | PMID:38568856 | SYTL3 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SYTL3 mRNA | CTD | PMID:37042841 | SYTL3 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of SYTL3 mRNA | CTD | PMID:18175754 | SYTL3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SYTL3 mRNA | CTD | PMID:29803840 | SYTL3 | Human | endosulfan | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of SYTL3 mRNA | CTD | PMID:29391264 | SYTL3 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SYTL3 gene | CTD | PMID:31601247 | SYTL3 | Human | furan | increases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | furan results in increased expression of SYTL3 mRNA | CTD | PMID:25539665 | SYTL3 | Human | GW 4064 | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | GW 4064 results in increased expression of SYTL3 mRNA | CTD | PMID:26655953 | SYTL3 | Human | lead diacetate | decreases expression | ISO | Sytl3 (Mus musculus) | 6480464 | lead acetate results in decreased expression of SYTL3 mRNA | CTD | PMID:21829687 | SYTL3 | Human | lead diacetate | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | lead acetate results in increased expression of SYTL3 mRNA | CTD | PMID:22609695 | SYTL3 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of SYTL3 mRNA | CTD | PMID:35811015 | SYTL3 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SYTL3 mRNA] | CTD | PMID:35811015 | SYTL3 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of SYTL3 intron | CTD | PMID:30157460 | SYTL3 | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of SYTL3 mRNA | CTD | PMID:24449571 | SYTL3 | Human | methoxychlor | affects methylation | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of SYTL3 gene | CTD | PMID:35440735 | SYTL3 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SYTL3 mRNA | CTD | PMID:23649840 | SYTL3 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Sytl3 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SYTL3 mRNA | CTD | PMID:36189433 | SYTL3 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of SYTL3 mRNA | CTD | PMID:24768652 and PMID:25583101 | SYTL3 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SYTL3 mRNA | CTD | PMID:35430440 | SYTL3 | Human | paracetamol | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SYTL3 mRNA | CTD | PMID:33387578 | SYTL3 | Human | perfluorooctanoic acid | multiple interactions | ISO | Sytl3 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SYTL3 mRNA | CTD | PMID:35163327 | SYTL3 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SYTL3 mRNA | CTD | PMID:22714537 | SYTL3 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of SYTL3 mRNA | CTD | PMID:26079696 | SYTL3 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of SYTL3 mRNA] | CTD | PMID:35811015 | SYTL3 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of SYTL3 mRNA | CTD | PMID:25895662 | SYTL3 | Human | silicon dioxide | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SYTL3 mRNA | CTD | PMID:29341224 | SYTL3 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SYTL3 mRNA | CTD | PMID:29301061 | SYTL3 | Human | sodium arsenite | decreases expression | ISO | Sytl3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SYTL3 mRNA | CTD | PMID:37682722 | SYTL3 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SYTL3 mRNA | CTD | PMID:31533062 | SYTL3 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of SYTL3 mRNA | CTD | PMID:31758290 | SYTL3 | Human | testosterone | multiple interactions | ISO | Sytl3 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:33848595 | SYTL3 | Human | testosterone | increases expression | ISO | Sytl3 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of SYTL3 mRNA | CTD | PMID:33848595 | SYTL3 | Human | tetrachloromethane | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of SYTL3 mRNA | CTD | PMID:31150632 | SYTL3 | Human | thioacetamide | increases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SYTL3 mRNA | CTD | PMID:23411599 | SYTL3 | Human | titanium dioxide | decreases expression | ISO | Sytl3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SYTL3 mRNA | CTD | PMID:29264374 | SYTL3 | Human | trichloroethene | decreases expression | ISO | Sytl3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of SYTL3 mRNA | CTD | PMID:33387578 | SYTL3 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SYTL3 mRNA | CTD | PMID:37042841 | SYTL3 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SYTL3 gene | CTD | PMID:29154799 | SYTL3 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SYTL3 mRNA | CTD | PMID:28001369 | SYTL3 | Human | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of SYTL3 mRNA | CTD | PMID:23649840 | |